BioPharmSignal logoBioPharmSignal

Biotech News

Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2025 Revenue

Treace Medical Concepts (TMCI)Treace Medical Concepts2026-06-25 13:46 ESTEarnings

PONTE VEDRA, Fla., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced its preliminary, unaudited

Open original release

Related news

TMCITreace Medical Concepts2026-06-25 13:46 EST

Treace Announces First Surgical Case with the HyperPlate™ XM Dynamic Compression Locking Implant System

TMCITreace Medical Concepts2026-06-25 13:46 EST

Treace to Present at the Sidoti Small Cap Conference

TMCITreace Medical Concepts2026-06-25 13:46 EST

Treace Medical Concepts Reports First Quarter 2026 Financial Results

TMCITreace Medical Concepts2026-06-25 13:46 EST

Treace Announces Participation in Two Upcoming Investor Conferences

TMCITreace Medical Concepts2026-06-25 13:46 EST

Treace Medical Secures Up to $175 Million in Debt Financing

TMCITreace Medical Concepts2026-06-25 13:46 EST

Treace to Present at 44th Annual J.P. Morgan Healthcare Conference

TMCITreace Medical Concepts2026-06-25 13:46 EST

Treace Announces First Surgical Case Utilizing Lapiplasty® Lightning™ Technology

TMCITreace Medical Concepts2026-06-25 13:46 EST

Treace Updates Date of Fourth Quarter and Full-Year 2025 Financial Results Release to February 27, 2026

TMCITreace Medical Concepts2026-06-25 13:46 EST

Treace Highlights New Product Innovations and Updated Positive Clinical Study Data at the 2026 ACFAS Annual Scientific Conference

TMCITreace Medical Concepts2026-06-25 13:46 EST

Treace Medical Concepts Reports Fourth Quarter and Full-Year 2025 Financial Results

View all latest news

Treace Medical Concepts

Treace Medical Concepts is a medical devices company focused on product adoption, procedure volume, and how clinical workflow converts into recurring demand.

Recent company news

TMCITreace Medical Concepts2026-06-26 13:22 EST

Treace Announces First Surgical Case with the HyperPlate™ XM Dynamic Compression Locking Implant System

TMCITreace Medical Concepts2026-06-26 13:22 EST

Treace to Present at the Sidoti Small Cap Conference

TMCITreace Medical Concepts2026-06-26 13:22 EST

Treace Medical Concepts Reports First Quarter 2026 Financial Results

TMCITreace Medical Concepts2026-06-26 13:22 EST

Treace Announces Participation in Two Upcoming Investor Conferences

TMCITreace Medical Concepts2026-06-26 13:22 EST

Treace Medical Secures Up to $175 Million in Debt Financing

Stock data

Close
—
Market cap
—
Exchange
NASDAQ
Sector
Biotechnology
Location
United States